ALLO - Allogene Therapeutics Q4 2022 Earnings Preview
- Allogene Therapeutics ( NASDAQ: ALLO ) is scheduled to announce Q4 earnings results on Tuesday, February 28th, after market close.
- The consensus EPS Estimate is -$0.69 and the consensus Revenue Estimate is $0.06M (compared to $51M in year ago quarter).
- Over the last 3 months, EPS estimates have seen 0 upward revisions and 1 downward.
For further details see:
Allogene Therapeutics Q4 2022 Earnings Preview